Adverum Biotechnologies Stock Z Score
ADVM Stock | USD 9.30 0.31 3.23% |
Adverum | Z Score |
Adverum Biotechnologies Company Z Score Analysis
Adverum Biotechnologies' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Adverum Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Adverum Biotechnologies is extremely important. It helps to project a fair market value of Adverum Stock properly, considering its historical fundamentals such as Z Score. Since Adverum Biotechnologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Adverum Biotechnologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Adverum Biotechnologies' interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition |
In accordance with the company's disclosures, Adverum Biotechnologies has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Adverum Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Adverum Biotechnologies' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Adverum Biotechnologies could also be used in its relative valuation, which is a method of valuing Adverum Biotechnologies by comparing valuation metrics of similar companies.Adverum Biotechnologies is currently under evaluation in z score category among related companies.
Adverum Biotechnologies Institutional Holders
Institutional Holdings refers to the ownership stake in Adverum Biotechnologies that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Adverum Biotechnologies' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Adverum Biotechnologies' value.Shares | Renaissance Technologies Corp | 2023-12-31 | 1.9 M | Blackrock Inc | 2023-12-31 | 1.4 M | Geode Capital Management, Llc | 2023-12-31 | 864.2 K | Newtyn Management Llc | 2023-12-31 | 823.1 K | Worth Venture Partners, Llc | 2023-12-31 | 784.3 K | Two Sigma Advisers, Llc | 2023-12-31 | 462.3 K | Two Sigma Investments Llc | 2023-12-31 | 446.4 K | Soleus Capital Management, L.p. | 2023-12-31 | 425 K | Quinn Opportunity Partners Llc | 2023-12-31 | 398.3 K | Commodore Capital Lp | 2023-12-31 | 10 M | Goldman Sachs Group Inc | 2023-12-31 | 9.1 M |
Adverum Fundamentals
Return On Equity | -0.88 | ||||
Return On Asset | -0.32 | ||||
Operating Margin | (34.38) % | ||||
Current Valuation | 171.53 M | ||||
Shares Outstanding | 20.76 M | ||||
Shares Owned By Insiders | 1.19 % | ||||
Shares Owned By Institutions | 88.49 % | ||||
Number Of Shares Shorted | 1.2 M | ||||
Price To Earning | (2.10) X | ||||
Price To Book | 2.92 X | ||||
Price To Sales | 67.63 X | ||||
Revenue | 3.6 M | ||||
Gross Profit | (81.68 M) | ||||
EBITDA | (118.15 M) | ||||
Net Income | (117.17 M) | ||||
Cash And Equivalents | 235.84 M | ||||
Cash Per Share | 2.37 X | ||||
Total Debt | 75.04 M | ||||
Debt To Equity | 0.43 % | ||||
Current Ratio | 8.03 X | ||||
Book Value Per Share | 8.23 X | ||||
Cash Flow From Operations | (91.32 M) | ||||
Short Ratio | 4.07 X | ||||
Earnings Per Share | (11.60) X | ||||
Target Price | 35.33 | ||||
Number Of Employees | 121 | ||||
Beta | 0.88 | ||||
Market Capitalization | 193.04 M | ||||
Total Asset | 173.01 M | ||||
Retained Earnings | (919.78 M) | ||||
Working Capital | 77.86 M | ||||
Current Asset | 260.99 M | ||||
Current Liabilities | 6.57 M | ||||
Net Asset | 173.01 M |
About Adverum Biotechnologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Adverum Biotechnologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adverum Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adverum Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adverum Biotechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adverum Biotechnologies' short interest history, or implied volatility extrapolated from Adverum Biotechnologies options trading.
Pair Trading with Adverum Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adverum Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Moving together with Adverum Stock
0.81 | EGRX | Eagle Pharmaceuticals | PairCorr |
Moving against Adverum Stock
0.83 | VRCA | Verrica Pharmaceuticals Earnings Call Tomorrow | PairCorr |
0.75 | JANX | Janux Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.71 | YCBD | cbdMD Inc Earnings Call Tomorrow | PairCorr |
0.62 | ELYM | Eliem Therapeutics Earnings Call Tomorrow | PairCorr |
0.45 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
The ability to find closely correlated positions to Adverum Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adverum Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adverum Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adverum Biotechnologies to buy it.
The correlation of Adverum Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adverum Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adverum Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adverum Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Adverum Biotechnologies Piotroski F Score and Adverum Biotechnologies Valuation analysis. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Adverum Stock analysis
When running Adverum Biotechnologies' price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Adverum Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.60) | Revenue Per Share 0.357 | Quarterly Revenue Growth (0.70) | Return On Assets (0.32) | Return On Equity (0.88) |
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.